Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Comparison of Beiyi® and its reference product Enantone® as agonists of luteinizing hormone-releasing hormone against prostate cancer: a multicenter, randomized single-dose study

Background Leuprolide acetate is a potent agonist of luteinizing hormone-releasing hormone that has been licensed to treat prostate cancer. The microsphere formulation of leuprolide acetate called Beiyi®, developed in China, has shown favorable pharmacokinetics, pharmacodynamics and safety similar to those of the refer...

Yu-Yao Yi, P. Shen, Tong-Sen Zheng et al. · 0 citations
Aug 2026

Ligilactobacillus salivarius NCU-41 reduces oxidative stress to ameliorate Parkinson's disease by regulating the AKT/Nrf2 signaling pathway.

A growing body of evidence suggests that the gut microbiota influences the onset and progression of Parkinson's disease (PD) by regulating oxidative stress pathways. However, existing evidence remains the phenotypic level, and high-quality research is still lacking regarding specific probiotic strains with clearly defi...

Tang-Chang Xu, Ming Lin, Qianyu Yong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.